跳至主要内容
临床试验/NCT06895187
NCT06895187尚未招募不适用

Catheter Ablation Using a Novel Navigation and Imaging System

LUMA Vision Ltd.0 个研究点目标入组 100 人开始时间: 2027年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
Acute procedural success rates during the index procedure

研究概览

简要总结

The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is 18 years of age at the time of consent, or of legal age to give informed consent specific to state and national law
  • Subjects is eligible for a catheter ablation procedure with the VERAFEYE System as navigation and imaging system in the treatment of PAF (according to VERAFEYE System IFUs, current international and local guidelines and per physician discretion)
  • Subject is able to understand and willing to provide written informed consent
  • Subject is able to and willing to complete all study assessments associated with this clinical study at an approved clinical investigational center

排除标准

  • 未提供

结局指标

主要结局

Acute procedural success rates during the index procedure

时间窗: During the procedure

A procedure will be defined as successful if all the following conditions occur during the case: * ability to create a 3D anatomical model with the VERAFEYE System and * completion of the necessary ablation applications for PAF using the 3D anatomical model created with the VERAFEYE System

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验